Developing new technologies for vaccines against infectious diseases
NIAID VRC NUCLEIC ACID AND LIPID TECHNOLOGY DEVELOPMENT
This study is working on new ways to make vaccines using DNA and RNA to help fight infections like COVID-19, HIV, and the flu, so that people can get better and faster protection when outbreaks happen.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10942128 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new vaccine technologies, particularly using nucleic acids like DNA and RNA, to combat infectious diseases. It aims to enhance the rapid manufacturing processes for vaccines, especially in response to outbreaks like COVID-19. By developing lipid nanoparticle formulations, the research seeks to improve the delivery and effectiveness of mRNA vaccines for various infectious diseases, including HIV and influenza. Patients may benefit from more effective and rapidly available vaccines as a result of this work.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk for infectious diseases such as COVID-19, HIV, and influenza.
Not a fit: Patients who are not at risk for infectious diseases or those who have already been vaccinated may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines that can be rapidly deployed during infectious disease outbreaks.
How similar studies have performed: Previous research has shown success in developing mRNA vaccines for COVID-19, indicating that similar approaches may be effective for other infectious diseases.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Coleman, Victoria — Leidos Biomedical Research, INC.
- Study coordinator: Coleman, Victoria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.